Advantest (ATEYY) Downgraded to Sell at Zacks Investment Research
Zacks Investment Research downgraded shares of Advantest (OTCMKTS:ATEYY) from a hold rating to a sell rating in a research note released on Wednesday.
According to Zacks, “Advantest Corporation is one of the world’s leading automatic test equipment suppliers to the semiconductor industry, and is also a producer of electronic and optoelectronic instruments and systems. A global company, Advantest has long offered total ATE solutions, and serves the industry in every component of semiconductor test: tester, handler, mechanical and electrical interfaces, and software. Its logic, memory, mixed-signal and RF testers, and device handlers, are integrated into the most advanced semiconductor fabrication lines in the world. “
Shares of Advantest (ATEYY) opened at $18.36 on Wednesday. Advantest has a 52 week low of $15.84 and a 52 week high of $23.40. The company has a debt-to-equity ratio of 0.26, a quick ratio of 3.02 and a current ratio of 4.04. The company has a market cap of $3,720.00, a P/E ratio of 55.64 and a beta of 0.44.
WARNING: This article was originally published by TheOlympiaReport and is owned by of TheOlympiaReport. If you are reading this article on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark legislation. The legal version of this article can be viewed at https://theolympiareport.com/2017/12/28/advantest-ateyy-downgraded-to-sell-at-zacks-investment-research.html.
Advantest Corporation manufactures and sells semiconductor and component test system products and mechatronics-related products, such as test handlers and device interfaces. The Company engages in research and development activities, and provides maintenance and support services associated with these products.
Receive News & Ratings for Advantest Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Advantest and related companies with Analyst Ratings Network's FREE daily email newsletter.